China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator

Democrats said the package was needed to fight a pandemic that has killed more than 500,000 Americans and thrown millions out of work

The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death

The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US

The House Rules Committee turned back scores of Republican attempts to modify the package and sent it to the House floor for passage late Friday or early Saturday

Union Information and Broadcasting Minister Prakash Javadekar said those who go to government centres will be administered the vaccine free of cost

Official data released on Friday showed factory output advanced 4.2% in January, boosted by sharp rises in production of electronic parts and general-purpose machinery, as well as a smaller increase in car output

MEA spokesperson Anurag Srivastava said the supply of vaccines to countries will continue in the coming weeks and months in a phased manner but it will be ensured that domestic requirements for the national vaccination programme are kept in mind

The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech

The ministry said in a statement that the deal is worth 1.6 billion reais ($290,000), with the first 8 million doses expected to arrive in March

The new variant, known as B.1.526, was first identified in samples collected in New York in November, and by mid-February represented about 12% of cases, researchers at Columbia University Vagelos College of Physicians and Surgeons, said on Wednesday

If you are above 45 and with comorbidities (with one or more diseases), you are eligible to get a Covid-19 jab. However, you'll have to produce a signed medical certificate, showing the severity of your illness

Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume

The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilised variant of the SARS-CoV-2 S protein.

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

The findings of the study become significant as in many parts of the world, mutant variants of the virus are causing a new surge in COVID-19 cases. The current increase in the number of infections in some Indian states may also be due to the presence of virus variants, it is feared

Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose

The government might engage private firms and institutions to vaccinate the 50-plus age group to cover a much larger target population of 27 crore individuals. It will also include below-50 age group with serious co-morbidities

Indian business tycoon and Wipro founder-chairman Azim Premji has suggested to the Centre to allow private sector participation in order to speed up the vaccination process against coronavirus. Premji added that with the involvement of the private firms and institutions in the COVID-19 vaccination drive, over 50 crore people can be inoculated within two months. Meanwhile, the Union Health Ministry has directed all states and union territories to enhance the pace of vaccination amid the recent surge in COVID-19 active cases, especially in five states. Watch the video for more.Also Read: 50 crore Indians can be vaccinated in two months with help from private sector: Azim Premji

An amount of Rs 1 lakh invested in the large cap stock on February 20 would have turned into Rs 2.56 lakh today